<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02985723</url>
  </required_header>
  <id_info>
    <org_study_id>2012-A01671-42</org_study_id>
    <nct_id>NCT02985723</nct_id>
  </id_info>
  <brief_title>Visual Outcome, Cylinder Correction and Patient Satisfaction After Implantation of AT LISA Tri Toric 939MP Intraocular Lenses</brief_title>
  <acronym>VICTORI</acronym>
  <official_title>Prospective Study to Evaluate the Visual Outcome, Cylinder Correction and Patient Satisfaction After Implantation of AT LISA Tri Toric 939MP Intraocular Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Carl Zeiss Meditec AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Carl Zeiss Meditec AG</source>
  <brief_summary>
    <textblock>
      The aim of the present study is to evaluate the postoperative visual acuity for distance,&#xD;
      intermediate and near vision as well as the cylinder correction and the patient satisfaction&#xD;
      after bilateral implantation of AT LISA tri toric 939MP IOLs.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Best distance-corrected visual acuity for intermediate vision after bilateral implantation</measure>
    <time_frame>12 months after surgery</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>939MP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>AT LISA tri toric 939MP intraocular lens</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AT LISA tri toric 939MP</intervention_name>
    <arm_group_label>939MP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient informed of the consequences and constraints of the protocol and who has given&#xD;
             his/her written informed consent&#xD;
&#xD;
          -  Man or woman, over 50 years of age&#xD;
&#xD;
          -  Healthy eyes with bilateral cataract requiring surgical treatment for both eyes&#xD;
&#xD;
          -  Bilateral regular corneal astigmatism (confirmed by topography measurement)&#xD;
&#xD;
          -  Only patients requiring intraocular lenses of a power comprised between sphere +0.0&#xD;
             and +28.0 dioptres and between a cylindrical range of +1.0 to +4.0D in both eyes will&#xD;
             be able to participate in the trial.&#xD;
&#xD;
          -  Biometry measurement/cataract density compatible with the IOLMaster evaluation&#xD;
&#xD;
          -  Bilateral uncomplicated cataract surgery and implantation into capsular bag by&#xD;
             injector&#xD;
&#xD;
          -  Assured follow-up examinations&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients unable to meet the limitations of the protocol or likely of non cooperation&#xD;
             during the trial,&#xD;
&#xD;
          -  Patients whose freedom is impaired by administrative or legal order,&#xD;
&#xD;
          -  Monophtalmic patient.&#xD;
&#xD;
          -  Previous ocular surgery, including corneal/refractive surgery,&#xD;
&#xD;
          -  Chronic or recurrent uveitis,&#xD;
&#xD;
          -  Acute ocular disease or external/internal infection,&#xD;
&#xD;
          -  Any kind of macular degeneration and impairment of retina (clinical diagnosis/OCT&#xD;
             examination)&#xD;
&#xD;
          -  Diabetes with retinal changes,&#xD;
&#xD;
          -  Pseudoexfoliation syndrome&#xD;
&#xD;
          -  Pathologic myosis&#xD;
&#xD;
          -  Irregular astigmatism, especially keratoconus,&#xD;
&#xD;
          -  Endothelial corneal dystrophy&#xD;
&#xD;
          -  Glaucoma or IOP higher than 21mmHg under ocular hypertension treatment&#xD;
&#xD;
          -  Aniridia&#xD;
&#xD;
          -  Pseudophakia&#xD;
&#xD;
          -  Cornea guttata; keratoplasty&#xD;
&#xD;
          -  Amotio operation; anamnesis with vitreous surgery&#xD;
&#xD;
          -  Amblyopia&#xD;
&#xD;
          -  Intraocular tumours; endotamponade&#xD;
&#xD;
          -  Phlogistic intraocular processes or other pre-existing processes that permanently&#xD;
             limit the best corrected visual acuity to &gt; 0.3 logMAR&#xD;
&#xD;
          -  Any other pathology or condition presenting, according to the investigator opinion, a&#xD;
             risk for the patient&#xD;
&#xD;
          -  Pupil diameter over 6 mm in mesopic condition&#xD;
&#xD;
          -  Corneal opacity&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Piovella, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CMA - Centro Microchirurgia Ambulatoriale</affiliation>
  </overall_official>
  <verification_date>January 2018</verification_date>
  <study_first_submitted>December 5, 2016</study_first_submitted>
  <study_first_submitted_qc>December 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 7, 2016</study_first_posted>
  <last_update_submitted>January 25, 2018</last_update_submitted>
  <last_update_submitted_qc>January 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

